J. Nathan Hagstrom - Concepedia

Author

J. Nathan Hagstrom

Also Known As

J Hagstrom, J N Hagstrom, J Nathan Hagstrom, J. Hagstrom, J. N. Hagstrom, J. Nathan Hagstrom, J.Nathan Hagstrom, JN Hagstrom

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Children's Hospital of Philadelphia Connecticut Children's Medical Center University of Connecticut Human Gene Therapy Research Institute

About

J. Nathan Hagstrom is an author at University of Pennsylvania specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.1K
2	Public Health	2	2	171
3	Engineering	1	1	22
4	Allergy	1	1	128
5	Biomedical Engineering	1	1	22

J. Nathan Hagstrom

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector Roland W. Herzog, Edmund Y. Yang, Linda B. Couto, Nature Medicine PathogenesisHematologyImmunologyVeterinary SciencePathology	1999	562
Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus Roland W. Herzog, J. Nathan Hagstrom, Szu-Hoo Kung, Proceedings of the National Academy of Sciences	1997	472
Adeno-Associated Viral Vector-Mediated Gene Transfer of Human Blood Coagulation Factor IX Into Mouse Liver Hiroyuki Nakai, Roland W. Herzog, J. Nathan Hagstrom, Blood	1998	185
Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease J. Nathan Hagstrom, Johannes Walter, Rachel Bluebond‐Langner, The Journal of Pediatrics ThrombopoiesisThrombosisVenous ThrombosisPediatric HematologyInherited Metabolic Disease	1998	141
Human Factor IX Corrects the Bleeding Diathesis of Mice With Hemophilia B Szu‐Hao Kung, J. Nathan Hagstrom, Darrell L. Cass, Blood	1998	129
Role of Vector in Activation of T Cell Subsets in Immune Responses against the Secreted Transgene Product Factor IX Paul Fields, Dariusz Kowalczyk, Valder R. Arruda, Molecular Therapy Factor IxAdaptive Immune SystemT-regulatory CellImmunologyTh2 Subsets	2000	128
Successful expression of human factor IX following repeat administration of adenoviral vector in mice. Johannes Walter, Qiang You, J. Nathan Hagstrom, Proceedings of the National Academy of Sciences Laboratory ImmunologyViral PathogenesisImmunologyPathologyImmunodominance	1996	127
Risk and Prevention of Anti-factor IX Formation in AAV-Mediated Gene Transfer in the Context of a Large Deletion of F9 Paul Fields, Valder R. Arruda, Elina Armstrong, Molecular Therapy GeneticsAav VectorImmunologyImmune RegulationPathology	2001	125
Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care Biree Andemariam, Jasmine Owarish‐Gross, James J. Grady, Pediatric Blood & Cancer	2013	82
Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter J. Nathan Hagstrom, Linda B. Couto, Ciaran D. Scallan, Blood	2000	74

Page 1